CHPT vs DRMAW
ChargePoint Holdings Inc (CHPT) versus Dermata Therapeutics Inc. Warrant (DRMAW) — a side-by-side from cached financials, not a winner call.
ChargePoint Holdings Inc (CHPT) is a specialty retail company listed on NYSE.
Dermata Therapeutics Inc. Warrant (DRMAW) common stock listed on NASDAQ.
Latest reported CHPT revenue for 2026-07-31 was $217.9M. Net income was -$78.8M. CHPT currently screens at market cap $199.2M.
DRMAW does not have a complete income-statement cache yet.
CHPT currently screens at market cap $199.2M. DRMAW currently screens at market cap $0.
Not investment advice. Open the CHPT and DRMAW stock pages for the full models.
Not investment advice.